{"id":"W2416345136","doi":"10.1021/acs.molpharmaceut.5b00425","title":"Radiation Nanomedicine for EGFR-Positive Breast Cancer: Panitumumab-Modified Gold Nanoparticles Complexed to the β-Particle-Emitter, <sup>177</sup>Lu","year":2015,"lang":"en","type":"article","venue":"Molecular Pharmaceutics","topic":"Radiation Therapy and Dosimetry","field":"Medicine","cited_by":85,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; University Health Network","funders":"Canadian Institutes of Health Research; Terry Fox Foundation; Canadian Cancer Society; Natural Sciences and Engineering Research Council of Canada; Amgen","keywords":"Nanomedicine; Nanoparticle; Panitumumab; Breast cancer; Chemistry; Colloidal gold; Nanotechnology; Cancer; Oncology; Radiochemistry; Medicine; Materials science; Internal medicine; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005849047,0.0002828315,0.0003771563,0.00009015013,0.0001672124,0.00005812831,0.0002233337,0.00009791007,0.00004542649],"category_scores_gemma":[0.0001205135,0.0002207256,0.0001372243,0.0005719343,0.000117642,0.0001125582,0.00004971812,0.0002246241,0.00005813379],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002984861,"about_ca_system_score_gemma":0.0001983619,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00008073551,"about_ca_topic_score_gemma":0.000005145514,"domain_scores_codex":[0.9979375,0.0001679266,0.0004503878,0.0003828329,0.0005301267,0.0005312042],"domain_scores_gemma":[0.9983434,0.0001410252,0.0001349091,0.0004172885,0.0003548127,0.0006085614],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.004138493,0.0007782422,0.008481738,0.0001409576,0.0008936097,0.0001026532,0.007416567,0.02518442,0.8155367,0.001493926,0.03197634,0.1038563],"study_design_scores_gemma":[0.01534806,0.0007126581,0.008249652,0.0001151932,0.0009617661,0.0001946639,0.001172298,0.172059,0.7418819,0.0002273025,0.05854232,0.0005351801],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9603865,0.002880742,0.004997557,0.02903226,0.0003107543,0.001849113,0.0002216879,0.0001265011,0.0001948574],"genre_scores_gemma":[0.9757228,0.0001302976,0.0004196652,0.02253496,0.0005247808,0.0002235828,0.0001030794,0.00006311645,0.0002777526],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1468746,"threshold_uncertainty_score":0.9000928,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05270284605040059,"score_gpt":0.3560531595300186,"score_spread":0.3033503134796181,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}